The Food and Drug Administration (FDA) issued a new policy on Feb. 29 for laboratories engaged in developing diagnostic tests for the coronavirus, allowing them to immediately respond to the public health emergency.
The new policy allows certain laboratories in the United States to develop testing capabilities in a health care setting.